Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,903Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Relpax

PharmaCompass

01

Brand Name : Relpax

Eletriptan Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

02

Brand Name : Relpax

Eletriptan Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Relpax

arrow
2024 ACI Convention
Not Confirmed

Eletriptan Hydrobromide

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 382

2014 Revenue in Millions : 352

Growth (%) : -8%

blank

03

Brand Name : Relpax

Eletriptan Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Relpax

arrow
2024 ACI Convention
Not Confirmed

Eletriptan Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 323

2015 Revenue in Millions : 352

Growth (%) : -8

blank

04

Brand Name : Relpax

Eletriptan Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Relpax

arrow
2024 ACI Convention
Not Confirmed

Eletriptan Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 236

2016 Revenue in Millions : 324

Growth (%) : -27

blank

05

Brand Name : Relpax

Eletriptan Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Relpax

arrow
2024 ACI Convention
Not Confirmed

Eletriptan Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 0

2017 Revenue in Millions : 236

Growth (%) : -100%

blank